Abstract: An AV sensor can be cleaned by charging a conductive layer over a sensor surface. The conductive layer may be positively or negatively charged and can repel contaminants having the same polarity away from the sensor. The charging of the conductive layer can be triggered by a determination that the sensor needs cleaning, which can be based on sensor data captured by the sensor or a different sensor. The charging of the conductive layer may include one or more charging cycles, each of which includes charging the conductive layer with two opposing polarities. Another conductive layer may be over the conductive layer. The other conductive layer can be charged with an opposite polarity from the conductive layer so that an electric field is present between the two conductive layers. A piezoelectric layer between the two conductive layers can vibrate under the electric field. The vibration can enhance the cleaning.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: An AV sensor can be cleaned by charging a conductive layer over a sensor surface. The conductive layer may be positively or negatively charged and can repel contaminants having the same polarity away from the sensor. The charging of the conductive layer can be triggered by a determination that the sensor needs cleaning, which can be based on sensor data captured by the sensor or a different sensor. The charging of the conductive layer may include one or more charging cycles, each of which includes charging the conductive layer with two opposing polarities. Another conductive layer may be over the conductive layer. The other conductive layer can be charged with an opposite polarity from the conductive layer so that an electric field is present between the two conductive layers. A piezoelectric layer between the two conductive layers can vibrate under the electric field. The vibration can enhance the cleaning.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: A method of authenticating a video streaming transmission comprising generating a secure token at an application server, providing the secure token to a user device, receiving the secure token at a media server with a publish request from the user device, transmitting the secure token to the application server for authentication, and authenticating the secure token. The publish request from the user device is enabled if the secure token is authenticated by the application server. The connection between the media server and the user device is terminated if the secure token fails to authenticate.

Abstract: A method of authenticating a video streaming transmission comprising generating a secure token at an application server, providing the secure token to a user device, receiving the secure token at a media server with a publish request from the user device, transmitting the secure token to the application server for authentication, and authenticating the secure token. The publish request from the user device is enabled if the secure token is authenticated by the application server. The connection between the media server and the user device is terminated if the secure token fails to authenticate.

Abstract: Embodiments are directed to compositions and methods for treating viral infections.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: Provided herein is a method of treating primary lung cancer or metastatic cancer to the lung in an individual by delivering at least once to the respiratory tract of the individual via inhalation a nebulized liposomal aerosol comprising a dilauroylphosphatidylcholine liposome containing camptothecin or a derivative thereof in an amount sufficient to deliver a pharmacologically effective dose of the camptothecin or its derivative to treat the cancer. Also provided is a nebulized liposomal aerosol comprising the DLPC containing the camptothecin or its derivative and a method of making the liposome-drug comprising the aerosol.

Abstract: The small particle liposome aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes. The liposomes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: The present invention provides a method of inhibiting growth of lung metastases in an individual comprising the steps of administering in a combination an aerosolized polyethylenimine-DNA complex and an aerosolized liposome-anticancer drug complex with both of the complexes delivered via aerosolization. Delivery of both the DNA and the anticancer drug via this method inhibits growth of lung metastases in the individual. Also provided is a method of inhibiting growth of lung metastases in an individual by the administration in combination via aerosolization of a polyethylenimine-p53 complex and a dilauroylphosphatidylcholine-9-nitrocamptothecin complex.

Abstract: The small particle liposome or lipid complex aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes or other lipid complexes. The liposomes and complexes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10,11 -methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: The small particle liposome or lipid complex aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes or other lipid complexes. The liposomes and complexes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: The small particle liposome or lipid complex aerosol compounds and methods of treatment of the present invention involve lipid- or water soluble anti-cancer drugs incorporated into liposomes or other lipid complexes. The liposomes and complexes are administered in aqueous dispersions from a jet nebulizer to the respiratory tract of an individual. Various anti-cancer drugs may be used, including 20-S-Camptothecin, 9-Nitro-camptothecin, 9-Amino-camptothecin, 10, 11-methylenedioxy-camptothecin and taxol or its derivatives. Administration of these drugs by inhalation provides faster and more efficient absorption of the anticancer drug than does intramuscular administration or oral administration.

Abstract: An internal combustion engine spark ignition system includes two inductors and a circuit for transferring energy from the inductors to a common spark circuit when current flow through the inductors is interrupted. Two transistors control current flow in the respective inductors and these are controlled by a control circuit which turns on and then off just one of the transistors when a normal spark is required, and which turns on both transistors and then turns these alternately on and off when an extended spark is required.